Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SECOND SIGHT MEDICAL PRODUCTS, INC.

(EYES)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Business Summary
Logo Second Sight Medical Products, Inc.
Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing implantable visual prosthetics devices that restore vision to blind individuals. The Company manufactures neuromodulation devices for blindness and engaged in developing new technologies to treat sight-impaired individuals. Its approved product, the Argus II Retinal Prosthesis System (Argus II), treats outer retinal degenerations, such as retinitis pigmentosa (RP). It is engaged in developing the Orion Visual Cortical Prosthesis System (Orion), an implanted cortical stimulation device, which provides artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion works by converting video images captured by a miniature camera housed in a userÔÇÖs glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes.

Number of employees : 12 people.
Sales per Business
20192020Delta
Implantable Visual Prosthetics3.38100%---
USD in Million
Managers
Name Title Age Since
Scott Dunbar Chief Executive Officer - 2021
Jessy Dorn, Dr. Vice President-Clinical & Scientific Affairs - 2006
Edward Randolph Vice President-Operations 62 2020
Aaron Mendelsohn Independent Director 68 1998
Gregg G. Williams Chairman 61 2018
Matthew J. Pfeffer Independent Director 63 2021
Wilford Dean Baker, Dr. Independent Director 77 2021
Edward Sedo Chief Accounting Officer - 2020
Members of the board
Name Title Age Since
Gregg G. Williams Chairman 61 2018
Aaron Mendelsohn Independent Director 68 1998
Matthew J. Pfeffer Independent Director 63 2021
Jonathan Will McGuire Director 57 2020
Wilford Dean Baker, Dr. Independent Director 77 2021
Alexandra Larson Director 40 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 39,409,176 29,463,821 74.8% 0 0.0% 74.8%
Shareholders
NameEquities%
Gregg G. Williams 9,890,810 25.1%
Empery Asset Management LP 3,300,000 8.37%
The Vanguard Group, Inc. 1,155,297 2.93%
Versant Venture Management LLC 561,612 1.43%
BlackRock Fund Advisors 399,886 1.01%
Hudson Bay Capital Management LP 380,404 0.97%
Altium Capital Management LP 373,867 0.95%
Susquehanna Financial Group LLLP 273,955 0.70%
NewGen Asset Management Ltd. 200,000 0.51%
Sabby Capital LLC 174,900 0.44%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Second Sight Medical Products, Inc.
Connections : Second Sight Medical Products, Inc.